Literature DB >> 23359164

Analysis of tumor-associated mucin glycotopes by Western transfer methods.

Vinayaga S Gnanapragassam1, Maneesh Jain, Surinder K Batra.   

Abstract

In mucins, glycosylation is complex and the most predominant posttranslational modification. Since mucins exhibit differential glycosylation pattern under physiological and pathological conditions, analysis of mucin glycans is important for understanding their specific functions during pathological conditions like cancer. Given the complexity of mucin glycans, several sophisticated analytical tools such as HPLC, mass spectrometry, and lectin sandwich assays are employed for glyco-analysis of mucins. However the specialized expertise and instrumentation required for such analysis are beyond the reach of an average cancer biology laboratory. We described in this chapter the utility of the simple electrophoresis/immunoblotting method to examine the mucin glycan epitopes, using specific antibodies and lectins.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359164      PMCID: PMC3645295          DOI: 10.1007/978-1-62703-287-2_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.

Authors:  Carol L Kinlough; Paul A Poland; Sandra J Gendler; Polly E Mattila; Di Mo; Ora A Weisz; Rebecca P Hughey
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Tricine-SDS-PAGE.

Authors:  Hermann Schägger
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines.

Authors:  M D Burdick; A Harris; C J Reid; T Iwamura; M A Hollingsworth
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

4.  MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.

Authors:  M P Ponnusamy; I Lakshmanan; M Jain; S Das; S Chakraborty; P Dey; S K Batra
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

Review 5.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

6.  Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

Authors:  Jennifer A Belisle; Sachi Horibata; Gubbels A A Jennifer; Sarah Petrie; Arvinder Kapur; Sabine André; Hans-Joachim Gabius; Claudine Rancourt; Joseph Connor; James C Paulson; Manish S Patankar
Journal:  Mol Cancer       Date:  2010-05-24       Impact factor: 27.401

7.  Vertical agarose gel electrophoresis and electroblotting of high-molecular-weight proteins.

Authors:  Chad M Warren; Paul R Krzesinski; Marion L Greaser
Journal:  Electrophoresis       Date:  2003-06       Impact factor: 3.535

Review 8.  Mucin-interacting proteins: from function to therapeutics.

Authors:  Shantibhusan Senapati; Srustidhar Das; Surinder K Batra
Journal:  Trends Biochem Sci       Date:  2009-11-11       Impact factor: 13.807

9.  Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier.

Authors:  Pablo Argüeso; Ana Guzman-Aranguez; Flavio Mantelli; Zhiyi Cao; Jessica Ricciuto; Noorjahan Panjwani
Journal:  J Biol Chem       Date:  2009-06-25       Impact factor: 5.157

Review 10.  Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.

Authors:  N Moniaux; M Andrianifahanana; R E Brand; S K Batra
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640

View more
  1 in total

1.  Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.

Authors:  Seema Chugh; Jane Meza; Yuri M Sheinin; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Br J Cancer       Date:  2016-05-17       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.